Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
74.47
-0.40 (-0.53%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Haemonetics Revenue
Haemonetics had revenue of $336.17M in the quarter ending June 29, 2024, with 7.98% growth. This brings the company's revenue in the last twelve months to $1.33B, up 9.47% year-over-year. In the fiscal year ending March 30, 2024, Haemonetics had annual revenue of $1.31B with 12.01% growth.
Revenue (ttm)
$1.33B
Revenue Growth
+9.47%
P/S Ratio
2.84
Revenue / Employee
$364,751
Employees
3,657
Market Cap
3.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 30, 2024 | 1.31B | 140.40M | 12.01% |
Apr 1, 2023 | 1.17B | 175.46M | 17.67% |
Apr 2, 2022 | 993.20M | 122.73M | 14.10% |
Apr 3, 2021 | 870.46M | -118.02M | -11.94% |
Mar 28, 2020 | 988.48M | 20.90M | 2.16% |
Mar 30, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Apr 1, 2017 | Pro | Pro | Pro |
Apr 2, 2016 | Pro | Pro | Pro |
Mar 28, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Oscar Health | 7.23B |
Surgery Partners | 2.89B |
Integer Holdings | 1.67B |
HUTCHMED (China) | 610.81M |
TransMedics Group | 358.76M |
ADMA Biologics | 330.24M |
Alvotech | 308.73M |
CRISPR Therapeutics AG | 202.23M |
HAE News
- 19 days ago - Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024 - PRNewsWire
- 2 months ago - Top 3 Health Care Stocks That Are Set To Fly This Quarter - Benzinga
- 2 months ago - Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System - PRNewsWire
- 2 months ago - Haemonetics Corporation (HAE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - PRNewsWire
- 3 months ago - Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire - PRNewsWire
- 3 months ago - Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 - PRNewsWire
- 4 months ago - Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth - Seeking Alpha